Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development.
about
Virus attenuation by genome-scale changes in codon pair biasVesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerTools for Single-Cell Kinetic Analysis of Virus-Host InteractionsUnderstanding and altering cell tropism of vesicular stomatitis virusChikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the BrainReverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector.Stimulation of human dendritic cells by wild-type and M protein mutant vesicular stomatitis viruses engineered to express bacterial flagellin.Gene order rearrangement of the M gene in the rabies virus leads to slower replication.Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organizationGenetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease.Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenicRecombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.Nonsegmented negative-strand viruses as vaccine vectors.Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primatesNew generation live vaccines against human respiratory syncytial virus designed by reverse genetics.Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it?Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.Construction of a Sonchus Yellow Net Virus minireplicon: a step toward reverse genetic analysis of plant negative-strand RNA viruses.Fitness analyses of vesicular stomatitis strains with rearranged genomes reveal replicative disadvantages.Lassa-vesicular stomatitis chimeric virus safely destroys brain tumorsRational attenuation of a morbillivirus by modulating the activity of the RNA-dependent RNA polymerase.Antigenic diversification is correlated with increased thermostability in a mammalian virus.Vesicular stomatitis viruses with rearranged genomes have altered invasiveness and neuropathogenesis in mice.Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cellsVesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host.Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing.Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine strain.Attenuated Infectious Hematopoietic Necrosis Virus with Rearranged Gene Order as Potential Vaccine.Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector.Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activitySignaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin.Evolutionarily stable attenuation by genome rearrangement in a virus.Transmissible Viral Vaccines.Arresting Evolution.Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin.Increased Virulence of an Epidemic Strain of Vesicular Stomatitis Virus Is Associated With Interference of the Innate Response in Pigs
P2860
Q24644457-A5B51CB6-F5FF-447D-9ACC-2599BE16EBCBQ27021839-CE901585-B423-4D6A-8BF5-7035E86904EBQ27334856-A686ED65-7392-49A4-8396-A590DFACA65FQ27687067-1EBE95AC-CEA0-44E8-9F71-792C61D7CFFAQ28223031-7F1AEEB3-2DAD-4B9D-AB7F-6E0BFEF4E575Q33570326-D046D73E-6E46-492F-BE44-CFF9C2E61073Q34262131-4BAE1BAD-3DC4-451C-A855-152BED5F0C42Q34296055-1ED24190-EE1C-42E2-8C84-43055FC5FB7BQ34300058-199A7C02-B102-4475-8471-C8C201B18885Q34351259-9F587A70-6E31-4726-9E86-7E8B365575E0Q34357917-442B6C72-84B5-493F-8E2E-BC22750ED53EQ34461764-82732CDC-64DC-44EE-8A67-8292370A6DF8Q34647625-7214FFBE-F1ED-4B08-883C-701448762922Q35139219-6AD59B50-CBDE-43F6-86C5-12508662EE00Q35635393-2DDA5D83-053F-4ADC-A032-9F6551F9DC2CQ35781967-68DB83BD-D57F-4C73-B90A-8F957F90AD71Q36237057-E533D7D1-7892-4C2A-A018-79B1A1499861Q36738542-622D6994-605E-4E25-8622-46E66D0ADC63Q36898706-92F1C994-F931-4960-8640-3C0E773AF8D5Q37252971-9057A532-7426-4772-B2AC-05F5086886E3Q37492459-90B065F4-3ECC-4CB7-941B-88408C2D5DEFQ38886667-93BEF6B0-7475-45D6-A08F-2C332B9F88CCQ39612879-7C227AFB-B99A-4E60-BF2D-FC697E6EAA82Q39655282-A90D7878-F952-4BF2-AF6C-931506D8E88BQ39748967-94DC1607-A0E5-4B51-BACF-565389342BDCQ39776032-8B8697DD-9F2E-4F0C-9B04-BE3ABAE941A7Q39776525-717E05D4-556F-44EB-9409-090477CC33AEQ39868272-2F1A6D72-509C-43A5-A23E-DE7636B73FC3Q40156113-9663007E-849C-4FD8-9A3E-168497BCAB63Q40348750-E6194636-724B-460D-87F4-01A77B4FE00DQ40524625-9EFC6FE2-D9B2-419E-BB22-ADA611F27EA3Q40619713-DFFE7464-470A-4C1A-B475-683A70A2965CQ41625843-E8C81CA1-3EFB-4609-BF48-A61F35C9611AQ41770092-4190A75C-7F22-4C41-9D33-71B982028C06Q41820076-6EEF81FF-25BD-4510-9B82-0A26E919C7A3Q42288506-BBCFDDCA-ADDE-42AB-AF54-A1FD7BE95721Q47443226-9B5F7EA4-69ED-45B0-86C2-F420B5619F48Q47446328-6BC47696-4E14-4FF2-8EF9-76EC4D3297EAQ53699705-59AE6960-9CA6-4961-B981-53F45D6A7BEEQ57004644-42DF3F13-AADF-47F8-8CD4-5CD8F42D3E2A
P2860
Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Rearrangement of the genes of ...... ategy for vaccine development.
@ast
Rearrangement of the genes of ...... ategy for vaccine development.
@en
type
label
Rearrangement of the genes of ...... ategy for vaccine development.
@ast
Rearrangement of the genes of ...... ategy for vaccine development.
@en
prefLabel
Rearrangement of the genes of ...... ategy for vaccine development.
@ast
Rearrangement of the genes of ...... ategy for vaccine development.
@en
P2093
P2860
P1433
P1476
Rearrangement of the genes of ...... ategy for vaccine development.
@en
P2093
E B Flanagan
J M Zamparo
L L Rodriguez
P2860
P304
P356
10.1128/JVI.75.13.6107-6114.2001
P577
2001-07-01T00:00:00Z